Abstract
Background: Mitigation of unwanted effects is a major issue to be addressed in drug discovery. The human genome shares a considerable degree of sequence identity and structural homology whereby multiple binding pockets of similar composition is seen across different family of proteins. This distribution of similar binding pockets in different proteins is a major reason for cross reactivity upon ligand binding. Therefore, identifying such off-targets on a case-to-case basis in the early stages of drug discovery pipeline is very much essential. Especially for developing specific ligands against isozymes such as glycogen phosphorylase it is a pre-requisite owing to its implications. The inhibitors of glycogen phosphorylase (GPi) control the blood glucose level effectively by inhibiting the hepatic GP (hGP). But due to its high degree of sequence identity with the muscle form (mGP) and similar binding pocket, these ligands cross react resulting in impaired muscle function due to prolonged relaxation. Therefore, molecular targeting or optimizing the lead to a specific target (hGP) is very essential. In the current work, a comparative docking approach was adopted wherein suitable ligands were designed based on the chemical descriptors present in lig18 binding site of mGP and hGP followed by virtual docking.
Results: The docking results showed that lig18 optimized compound (lig18_7) had better affinity to hGP and mGP respectively. lig18_7 interacted with residues Arg171 and Asn172 that are present specifically in hGP indicating specificity. Using this improved comparative docking approach isoform- specific ligands can be effectively developed.Keywords: Comparative docking, Glycogen phosphorylase, Glycogen phosphorylase inhibitors, Pentacyclic triterpenes, Cross reactivity.
Current Topics in Medicinal Chemistry
Title:An Improved Comparative Docking Approach for Developing Specific Glycogen Phosphorylase Inhibitors Using Pentacyclic Triterpenes
Volume: 17 Issue: 14
Author(s): V. Badireenath Konkimalla*
Affiliation:
- School of Biological Sciences, National Institute of Science Education and Research (NISER), POBhimpur- Padanpur, Via- Jatni, Khurda – 752050,India
Keywords: Comparative docking, Glycogen phosphorylase, Glycogen phosphorylase inhibitors, Pentacyclic triterpenes, Cross reactivity.
Abstract: Background: Mitigation of unwanted effects is a major issue to be addressed in drug discovery. The human genome shares a considerable degree of sequence identity and structural homology whereby multiple binding pockets of similar composition is seen across different family of proteins. This distribution of similar binding pockets in different proteins is a major reason for cross reactivity upon ligand binding. Therefore, identifying such off-targets on a case-to-case basis in the early stages of drug discovery pipeline is very much essential. Especially for developing specific ligands against isozymes such as glycogen phosphorylase it is a pre-requisite owing to its implications. The inhibitors of glycogen phosphorylase (GPi) control the blood glucose level effectively by inhibiting the hepatic GP (hGP). But due to its high degree of sequence identity with the muscle form (mGP) and similar binding pocket, these ligands cross react resulting in impaired muscle function due to prolonged relaxation. Therefore, molecular targeting or optimizing the lead to a specific target (hGP) is very essential. In the current work, a comparative docking approach was adopted wherein suitable ligands were designed based on the chemical descriptors present in lig18 binding site of mGP and hGP followed by virtual docking.
Results: The docking results showed that lig18 optimized compound (lig18_7) had better affinity to hGP and mGP respectively. lig18_7 interacted with residues Arg171 and Asn172 that are present specifically in hGP indicating specificity. Using this improved comparative docking approach isoform- specific ligands can be effectively developed.Export Options
About this article
Cite this article as:
Konkimalla Badireenath V.*, An Improved Comparative Docking Approach for Developing Specific Glycogen Phosphorylase Inhibitors Using Pentacyclic Triterpenes, Current Topics in Medicinal Chemistry 2017; 17 (14) . https://dx.doi.org/10.2174/1568026617666161104110045
DOI https://dx.doi.org/10.2174/1568026617666161104110045 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vitamin B<sub>12</sub> Deficiency Among the Healthy Jordanian Adult Population: Diagnostic Levels, Symptomology and Risk Factors
Endocrine, Metabolic & Immune Disorders - Drug Targets Strategies to Overcome Drug Resistance of Receptor Tyrosine Kinaseaddicted Cancer Cells
Current Medicinal Chemistry Plant Troponoids: Chemistry, Biological Activity, and Biosynthesis
Current Medicinal Chemistry Amino Acid Degrading Enzymes and their Application in Cancer Therapy
Current Medicinal Chemistry Challenges in the Management of Paediatric Febrile Neutropenia
Current Pediatric Reviews Synthesis and Preliminary Biological Evaluation of Chrysin Derivatives as Potential Anticancer Drugs
Medicinal Chemistry Prostaglandins Pathway as a Possible Biological Link Between Cancer and Major Depression
Current Angiogenesis (Discontinued) RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer
Current Cancer Drug Targets Pharmacogenomics: A Tool to Prevent and Cure Coronary Heart Disease
Current Pharmaceutical Design Immunomodulatory Effects of <i>Allium sativum</i> L. and its Constituents against Viral Infections and Metabolic Diseases
Current Topics in Medicinal Chemistry Induced pluripotent stem cell-derived mesenchymal stem cells: A leap toward personalized therapies.
Current Stem Cell Research & Therapy Editorial: (Thematic Issue): The Pathogenesis of Inflammation and Cancer in the Gastrointestinal Tract: From Basic Science to Translational Medicine
Current Pharmaceutical Design Novel Therapeutic Strategies Against Cancer: Marine-derived Drugs May Be the Answer?
Anti-Cancer Agents in Medicinal Chemistry EGFR and the Complexity of Receptor Crosstalk in the Cardiovascular System
Current Molecular Medicine Agonists and Antagonists of Protease Activated Receptors (PARs)
Current Medicinal Chemistry Xeno-Cannibalism as an Exacerbation of Self-Cannibalism: A Possible Fruitful Survival Strategy for Cancer Cells
Current Pharmaceutical Design The Colostrum Proteome, Ruminant Nutrition and Immunity: A Review
Current Protein & Peptide Science IL-17 and its Receptor Complex as Therapeutic Targets in Arthritis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Hedgehog Signaling in the Normal and Neoplastic Mammary Gland
Current Drug Targets Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
Current Drug Targets